Throughput-Scalable Manufacturing of SARS-CoV-2 mRNA Lipid Nanoparticle Vaccines

Scientists developed a microfluidic chip that incorporated 1×, 10×, or 256× lipid nanoparticle (LNP)-generating units that achieved scalable production rates of up to 17 L/h of precisely defined LNPs.